Literature DB >> 8385534

The influence of the gamma 2L subunit on the modulation of responses to GABAA receptor activation.

A L Horne1, P C Harkness, K L Hadingham, P Whiting, J A Kemp.   

Abstract

1. Whole-cell patch clamp recordings were made from L-cells transfected with 2 combinations of subunits of the GABAA receptor. Log concentration-response curves were constructed to gamma-aminobutyric acid (GABA) on alpha 1,beta 1,gamma 2L containing cells and compared to those from alpha 1,beta 1 containing cells. The effects of flunitrazepam, pentobarbitone and alphaxalone on the concentration-response relationships were also examined. 2. From the log concentration-response curves, GABA had a mean (+/- s.e. mean) pEC50 = 5.2 +/- 0.09 and slope factor = 1.7 +/- 0.02 on alpha 1,beta 1,gamma 2L cells which were significantly different from the values obtained from alpha 1,beta 1 cells where the pEC50 = 5.6 +/- 0.02 and the slope = 1.5 +/- 0.02. 3. Flunitrazepam produced a parallel leftward shift of GABA concentration-response curves on alpha 1,beta 1,gamma 2L cells. The EC50 for flunitrazepam = 6.3 +/- 2.7 nM. No increase in the maxima of the GABA concentration-response curves was found in the presence of flunitrazepam. Flunitrazepam did not potentiate responses from alpha 1,beta 1 cells. 4. The log concentration-response curves from both populations of cells were shifted to the left by equal amounts by pentobarbitone. A significant increase in the maximal response to GABA was also produced by pentobarbitone. This occurred at lower concentrations of pentobarbitone on alpha 1,beta 1 cells. 5. Alphaxalone produced leftward shifts of GABA log concentration-response curves of similar magnitudes in both populations of cells. Significant increases in the maxima were found at 100 nM in alpha 1, beta 1 cells but not up to 1 microM in alpha 1,beta 1,gamma 2L cells.6. These results provide further evidence of the modulatory role of the gamma 2L subunit of the GABAA receptor containing alpha 1 and beta 2 subunits. As well as influencing the apparent affinity of GABA and conferring benzodiazepine modulation, it also appeared to regulate the increase in maximal response produced in the presence of barbiturates and steroids. This latter effect may imply that barbiturates and steroids increase the channel open-state probability in the presence of GABA and that this effect is diminished by the presence of the gamma 2L subunit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385534      PMCID: PMC1908038          DOI: 10.1111/j.1476-5381.1993.tb12866.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sites.

Authors:  K L Hadingham; P C Harkness; R M McKernan; K Quirk; B Le Bourdellès; A L Horne; J A Kemp; E A Barnard; C I Ragan; P J Whiting
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site.

Authors:  P Whiting; R M McKernan; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients.

Authors:  A V Hill
Journal:  J Physiol       Date:  1909-12-23       Impact factor: 5.182

4.  Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.

Authors:  P Whiting; R Schoepfer; J Lindstrom; T Priestley
Journal:  Mol Pharmacol       Date:  1991-10       Impact factor: 4.436

5.  Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.

Authors:  G Puia; S Vicini; P H Seeburg; E Costa
Journal:  Mol Pharmacol       Date:  1991-06       Impact factor: 4.436

6.  Chlordiazepoxide selectively augments GABA action in spinal cord cell cultures.

Authors:  D W Choi; D H Farb; G D Fischbach
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

7.  Pharmacological and Electrophysiological Properties of Recombinant GABAA Receptors Comprising the alpha3, beta1 and gamma2 Subunits.

Authors:  F. Knoflach; K. H. Backus; T. Giller; P. Malherbe; P. Pflimlin; H. Möhler; G. Trube
Journal:  Eur J Neurosci       Date:  1992-10       Impact factor: 3.386

8.  Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture.

Authors:  J L Barker; B R Ransom
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

9.  The effects of benzodiazepine agonists, inverse agonists and Ro 15-1788 on the responses of the superior cervical ganglion to GABA in vitro.

Authors:  H J Little
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

10.  Distinction between the effects of barbiturates, benzodiazepines and phenytoin on responses to gamma-aminobutyric acid receptor activation and antagonism by bicuculline and picrotoxin.

Authors:  M A Simmonds
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

View more
  15 in total

1.  Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.

Authors:  Manish Kumar; Glenn H Dillon
Journal:  Eur J Pharmacol       Date:  2016-02-09       Impact factor: 4.432

2.  A role for the 2' residue in the second transmembrane helix of the GABA A receptor gamma2S subunit in channel conductance and gating.

Authors:  T Luu; B Cromer; P W Gage; M L Tierney
Journal:  J Membr Biol       Date:  2005-05       Impact factor: 1.843

3.  Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform.

Authors:  A M Lavoie; J J Tingey; N L Harrison; D B Pritchett; R E Twyman
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

4.  Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties [corrected; erratum to be published].

Authors:  P J Whiting; G McAllister; D Vassilatis; T P Bonnert; R P Heavens; D W Smith; L Hewson; R O'Donnell; M R Rigby; D J Sirinathsinghji; G Marshall; S A Thompson; K A Wafford; D Vasilatis
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

5.  Alpha subunit isoform influences GABA(A) receptor modulation by propofol.

Authors:  M D Krasowski; S M O'Shea; C E Rick; P J Whiting; K L Hadingham; C Czajkowski; N L Harrison
Journal:  Neuropharmacology       Date:  1997-07       Impact factor: 5.250

6.  The composition of the GABA receptor at the Caenorhabditis elegans neuromuscular junction.

Authors:  Bruce A Bamber; Janet E Richmond; James F Otto; Erik M Jorgensen
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

7.  Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes.

Authors:  D Belelli; H Callachan; C Hill-Venning; J A Peters; J J Lambert
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 8.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

9.  Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.

Authors:  S A Thompson; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery.

Authors:  A Concas; M C Mostallino; P Porcu; P Follesa; M L Barbaccia; M Trabucchi; R H Purdy; P Grisenti; G Biggio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.